Salient to Investors:
The OMX Copenhagen 20 Index:
- Returned 21% (18% in US dollars) in 2014 including dividends – the best benchmark gain in 24 developed markets – versus 9.6% for the S&P 500.
- Returned 280% (299% in US dollars) including dividends since its low in March 2009 versus 229% for the S&P 500 since its low 3 days later.
- Trades for 22.7 x earnings versus 17.7 for the S&P 500 and has been at a premium most of the time since the low in 2009, but was most of the time at a discount for the decade before that.
Novo Nordisk, the world’s largest insulin maker, accounts for 38% of the Copenhagen 20 – more than 10 times the most heavily weighted stock in the S&P 500, Apple.
Weaker currencies tends to lift stock prices of companies that book a lot of revenue in dollars.
Read the full article at http://www.bloomberg.com/news/2014-08-20/something-bullish-in-state-of-denmark-as-stock-gains-double-u-s-.html
Click here to receive free and immediate email alerts of the latest forecasts.